Play all audios:
Long non-coding RNAs (lncRNAs) have been demonstrated to be critical regulators in tumorigenesis. LncRNA SPRY4-IT1 has been identified as critical regulator for hepatocellular carcinoma and
ovarian cancer. However, the potential role and clinical value of SPRY4-IT1 in human thyroid cancer (TC) still remain unclear and need to be uncovered. Our current study was aimed to
ascertain the biological role of expression of SPRY4-IT1 in TC tissues and cells. Our findings revealed that the level of SPRY4-IT1 was significantly upregulated in TC tissues and cell
lines, which was correlated with poor prognosis. And cellular experiments exhibited that silenced SPRY4-IT1 inhibited the proliferative and migratory abilities of TC cells. Mechanism assays
noted that silenced SPRY4-IT1 could increase the levels of transforming growth factor-β1 (TGF-β1) and p-Smad2/3 and function mediated by si-SPRY4-IT1 could be rescued by the interference of
TGF-β1. Generally speaking, these findings elucidated that SPRY4-IT1 might become a novel prognostic factor in the clinical behaviors of TC patients and participated in the progression of TC
through targeting TGF-β/Smad signaling pathway.
School of Food Science, Henan Institute of Science and Technology, Xinxiang, Henan Province, 453000, China
Institute of Tropical Agriculture and Forestry, Hainan University, Haikou, Hainan Province, 570228, China
School of resources and environment, Henan Institute of Science and Technology, Xinxiang, Henan Province, 453000, China
ENT & HN Surgery Department, The First Affiliated Hospital of Hainan Medical University, Haikou, Hainan Province, 570102, China
Anyone you share the following link with will be able to read this content: